CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

Editas Medicine ( (EDIT) ) has provided an announcement. Editas Medicine announced new in vivo preclinical proof of concept data and outlined its strategic priorities and key milestones for 2025, ...

It feels fantastic,” said Blau, who thanked her lab members and colleagues for their support and dedication. “This ...

CRISPR-Cas9 pioneer presented with National Medal of Technology and Innovation in White House awards ceremony.

Kansas State University researchers have reported a breakthrough in developing wheat-based foods that contain lower amounts ...

Colossal Biosciences is now valued at over $10 billion and is working on ambitious projects to resurrect multiple long ...

Gene editing involves precise changes in DNA sequences using enzymes, revolutionizing medical, agricultural, and research fields globally.

2025-2027 Strategic Priorities Financial Items As a pioneering gene editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas12a and CRISPR/Cas9 genome ...

China-born biologist Zhang Feng has been awarded the United States’ highest honour for technological achievement in a ceremony at the White House, alongside eight other recipients. Zhang, an MIT ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...